Cover Image

Management of refractory pruritus in Alagille syndrome with dupilumab treatment: A case report

Saved in:

Bibliographic Details
Main Authors:	Daniel S. Alicea, MS (Author), Rachel Santana Felipes, BS (Author), Beth N. McLellan, MD (Author)
Format:	Book
Published:	Elsevier, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus
by: Warner Robinson, DDS, et al.
Published: (2023)

Refractory pruritus responds to dupilumab in a patient with TTC7A mutation
by: Yassaman Alipour Tehrany, MD, et al.
Published: (2021)

Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab
by: Nicole Edmonds, BA, et al.
Published: (2022)

Recalcitrant anal and genital pruritus treated with dupilumab
by: E.J. Yang, BS, et al.
Published: (2018)

Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab
by: Thomas Buttgereit, MD, et al.
Published: (2021)

Topical tacrolimus for refractory superficial mucoceles in a patient with chronic graft versus host disease
by: Alana Deutsch, BA, et al.
Published: (2020)

The use of dupilumab for the treatment of recalcitrant brachioradial pruritus
by: Mary Kathryn Abel, AB, et al.
Published: (2021)

Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study
by: Yutaka Inaba, et al.
Published: (2022)

Therapeutics Development for Alagille Syndrome
by: Phillip Sanchez, et al.
Published: (2021)

Manganese Poisoning in Alagille's Syndrome
by: J Gordon Millichap
Published: (1992)

Rapid resolution of widespread cutaneous lichen planus and generalized pruritus in an elderly patient following treatment with dupilumab
by: Soroush Kazemi, BS, et al.
Published: (2022)

Macrodontic maxillary incisor in alagille syndrome
by: Mauro Cozzani, et al.
Published: (2012)

Alagille syndrome: Review of 14 patients
by: Purnamawati S. Pujiarto, et al.
Published: (2017)

Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab
by: Kalisa Lum, BS, et al.
Published: (2024)

Upadacitinib as a treatment for chronic pruritus secondary to polycythemia vera after failure with dupilumab
by: Christopher I. Wachuku, MS, et al.
Published: (2023)

Real‐world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa
by: Ping‐Chen Hou, et al.
Published: (2024)

Dupilumab as an innovative therapy for symptomatic management of chemotherapy‐induced pruritus: A case series
by: Nupur Singh, et al.
Published: (2024)

Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
by: Nicholas A. Trum, BS, et al.
Published: (2021)

Alagille syndrome- A rare autosomal dominant disorder
by: Rizwan-, et al.
Published: (2018)

Clinical and genetic analysis in Chinese children with Alagille syndrome
by: Ying Chen, et al.
Published: (2022)

Diverse renal manifestations of Alagille syndrome in Korean children
by: Jinwoon Joung, et al.
Published: (2022)

Permasalahan Diagnostik Sindrom Alagille
by: Purnamawati SP, et al.
Published: (2016)

Peripheral Circumferential Chorioretinal Atrophy in a Patient with Alagille Syndrome
by: Shinji Makino, et al.
Published: (2016)

Arteriohepatic Dysplasia (Alagille Syndrome) in a Child (Clinical Case)
by: Ye.V. Omelchenko, et al.
Published: (2015)

Alagille Syndrome: A Novel Mutation in JAG1 Gene
by: Rita Fischetto, et al.
Published: (2019)

Corrigendum to "Diverse renal manifestations of Alagille syndrome in Korean children"
by: Jinwoon Joung, et al.
Published: (2023)

[Translated article] Successful Control of Recalcitrant Pruritus in Epidermolysis Bullosa Pruriginosa With Dupilumab
by: B. Roque Quintana, et al.
Published: (2024)

Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus
by: Lauren C. LaMonica, MPH, et al.
Published: (2023)

Can't handle the itch? Refractory immunotherapy-related transient acantholytic dermatosis: prompt resolution with dupilumab
by: Eva Shelton, BS, et al.
Published: (2022)

Clinical, pathological and genetic characteristics of 17 unrelated children with Alagille Syndrome
by: Jianguo Yan, et al.
Published: (2024)

Increased levels of chitotriosidase in a patient with Alagille syndrome: association or coincidence?
by: Bruna L. Diniz, et al.
Published: (2018)

Effect of Dupilumab on Generalized Verrucosis in Refractory Bullous Pemphigoid
by: Qijun Wang, et al.
Published: (2023)

Dupilumab and tezepelumab in severe refractory asthma: new opportunities
by: Beatrice Ragnoli, et al.
Published: (2022)

Multiple congenital anomalies: A suspected case of alagille syndrome variant in a Nigerian child
by: Edobor Festus Emiogun, et al.
Published: (2022)

Alagille syndrome and a mutation: 41 cases of experience at a single center
by: Kyung Jin Ahn, et al.
Published: (2015)

Peritoneal dialysis in an adult patient with tetralogy of Fallot diagnosed with incomplete Alagille syndrome
by: Malgorzata Ponikowska, et al.
Published: (2020)

Severe onycholysis and eyelash trichomegaly in a patient treated with erdafitinib
by: Alana Deutsch, BA, et al.
Published: (2020)

Utilization of scalp cooling to prevent chemotherapy-induced alopecia in woman of skin of color with type 3 hair
by: Warner Robinson, DDS, et al.
Published: (2024)

Case Report: Novel JAG1 gene mutations in two infants with alagille syndrome characterized by cholestasis
by: Yijiang Han, et al.
Published: (2022)

Characteristics and Outcome of Liver Transplantation in Children with Alagille Syndrome: A Single-center Experience
by: Chi-Ning Lee, et al.
Published: (2014)